文献速递腹部技术与安全USMR

基于参考频率法的超声谐波成像定量评估肝脏脂肪变性的新方法

Novel Quantitative Liver Steatosis Assessment Method With Ultrasound Harmonic Imaging.
PubMed 文献 · J Ultrasound Med · 2024-09-24

前瞻性纳入130例受试者,比较基波与谐波成像下参考频率法超声衰减系数估计(RFM-ACE-FI与RFM-ACE-HI)诊断肝脏脂肪变性的效能,以MRI-PDFF为参考。RFM-ACE-HI与MRI-PDFF相关性R=0.88,诊断S≥1和S≥2级脂肪变的AUROC分别为0.97和0.98,观察者间一致性R=0.97。

要点

  • RFM-ACE-HI与MRI-PDFF强相关(R=0.88),诊断S≥1和S≥2级脂肪变AUROC达0.97和0.98。
  • RFM-ACE-FI诊断S≥1和S≥2级脂肪变AUROC分别为0.76和0.80,低于谐波成像。
  • RFM-ACE-HI观察者间一致性R=0.97,重复性好。

核心结论

  • 新型RFM-ACE-HI方法对肝脏脂肪变性具有高诊断准确性和可重复性,对早期疾病干预和治疗评估有重要临床意义。

研究设计与样本

  • 机构审查委员会批准的前瞻性研究,2018年12月至2022年10月纳入130例受试者,以MRI-PDFF为参考标准,比较RFM-ACE-FI与RFM-ACE-HI的诊断效能,并由两名超声医师评估RFM-ACE-HI的观察者间一致性。

诊断标准与关键数值

  • RFM-ACE-HI与MRI-PDFF相关性R=0.88(95%CI 0.83-0.92,P<.001)。
  • RFM-ACE-FI与MRI-PDFF相关性R=0.65(95%CI 0.50-0.76,P<.001)。
  • RFM-ACE-HI诊断S≥1级脂肪变AUROC=0.97(95%CI 0.91-0.99,P<.001),S≥2级AUROC=0.98(95%CI 0.93-1.00,P<.001)。
  • RFM-ACE-FI诊断S≥1级脂肪变AUROC=0.76(95%CI 0.65-0.85),S≥2级AUROC=0.80(95%CI 0.70-0.88)。
  • RFM-ACE-HI观察者间一致性R=0.97(95%CI 0.94-0.99,P<.001)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disorder in Western countries, with approximately 20%-30% of the MASLD patients progressing to severe stages. There is an urgent need for noninvasive, cost-effective, widely accessible, and precise biomarkers to evaluate liver steatosis. This study aims to assess and compare the diagnostic performance of a novel reference frequency method-based ultrasound attenuation coefficient estimation (ACE) in both fundamental (RFM-ACE-FI) and harmonic (RFM-ACE-HI) imaging for detecting and grading liver steatosis.

METHODS: An Institutional Review Board-approved prospective study was carried out between December 2018 and October 2022. A total number of 130 subjects were enrolled in the study. The correlation between RFM-ACE-HI values and magnetic resonance imaging proton density fat fraction (MRI-PDFF), as well as between RFM-ACE-FI values and MRI-PDFF were calculated. The diagnostic performance of RFM-ACE-FI and RFM-ACE-HI was evaluated using receiver operating characteristic (ROC) curve analysis, as compared to MRI-PDFF. The reproducibility of RFM-ACE-HI was assessed by interobserver agreement between two sonographers.

RESULTS: A strong correlation was observed between RFM-ACE-HI and MRI-PDFF, with R = 0.88 (95% confidence interval [CI]: 0.83-0.92; P < .001), while the correlation between RFM-ACE-FI and MRI-PDFF was R = 0.65 (95% CI: 0.50-0.76; P < .001). The area under the ROC (AUROC) curve for RFM-ACE-HI in staging liver steatosis grades of S ≥ 1 and S ≥ 2 was 0.97 (95% CI: 0.91-0.99; P < .001) and 0.98 (95% CI: 0.93-1.00; P < .001), respectively, and 0.76 (95% CI: 0.65-0.85) and 0.80 (95% CI: 0.70-0.88) for RFM-ACE-FI, respectively. Great reproducibility was achieved for RFM-ACE-HI, with an interobserver agreement of R = 0.97 (95% CI: 0.94-0.99; P < .001).

CONCLUSIONS: The novel RFM-ACE-HI method offered high liver steatosis diagnostic accuracy and reproducibility, which has important clinical implications for early disease intervention and treatment evaluation.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Gong P, Zhang J, Huang C, et al. Novel Quantitative Liver Steatosis Assessment Method With Ultrasound Harmonic Imaging. J Ultrasound Med. 2024. PMID: 39315751. doi:10.1002/jum.16582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。